Egyptian e-health startup Nawah Scientific raised Cairo Angels Syndicate Fund led capital
As part of its continuing Series A round, Egyptian life sciences and biotech firm Nawah Scientific has received investment from the Cairo Angels Syndicate Fund (CASF).
Nawah Scientific, which was founded in 2015, is an online platform that takes experiment requests, gathers samples, executes tests, and digitally provides the results. Its goal is to allow scientists to undertake better research regardless of their location or access to lab facilities.
The company has become an important element of Egypt’s pharmaceutical business, having analysed over 200,000 samples from customers in 12 countries.
Nawah Scientific is working on a Series A after completing a US$1 million pre-Series A round early last year, and has acquired funding from the Cairo Angels Syndicate Firm (CASF), a micro venture capital fund that invests in early-stage businesses in the Middle East and Africa. Nawah Scientific was originally funded by the Cairo Angels network in 2020, and this round of funding is aimed at assisting the firm in maintaining its growth and onboarding new projects.
“We had the honour of having individual angel investors from the Cairo Angels network as early investors. They came in when we needed them the most, provided us with capital, networking, support and, most importantly, with faith in what we are building. Now, Cairo Angels come with their Syndicate Fund to double down on the success we have built together, and I’m very excited about what is yet to come,” said Dr Omar Sakr, founder and CEO of Nawah Scientific.
“Dr Omar is a perfect example of what I call “brain regain”, a super talented and ambitious founder who, if truth be told, we would have lost in previous years to North America or Europe, were it not for the recent changes that have made it possible for entrepreneurs to succeed at home. Not only has Dr Omar built an amazing, globally competitive and impactful business, but he has created a virtuous cycle for top scientists from Egypt to also succeed at home. We are immensely proud that we can continue to support Nawah Scientific in its mission,” said Aly El Shalakany, CEO of the Cairo Angels Syndicate Fund.